47 related articles for article (PubMed ID: 35772961)
1. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma.
Wang Y; Zhang Y; Li Y; Huang J
Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754
[TBL] [Abstract][Full Text] [Related]
2. Endothelial phosphodiesterase 4B inactivation ameliorates endothelial-to-mesenchymal transition and pulmonary hypertension.
Xing Y; Hou Y; Fan T; Gao R; Feng X; Li B; Pang J; Guo W; Shu T; Li J; Yang J; Mao Q; Luo Y; Qi X; Yang P; Liang C; Zhao H; Chen W; Wang J; Wang C
Acta Pharm Sin B; 2024 Apr; 14(4):1726-1741. PubMed ID: 38572107
[TBL] [Abstract][Full Text] [Related]
3. PDE4B Is a Homeostatic Regulator of Cyclic AMP in Dendritic Cells.
Chinn AM; Salmerón C; Lee J; Sriram K; Raz E; Insel PA
Front Pharmacol; 2022; 13():833832. PubMed ID: 35387344
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to: Characterization of 2 Novel Phosphodiesterase 2 Inhibitors Hcyb1 and PF-05180999 on Depression- and Anxiety-Like Behavior.
Int J Neuropsychopharmacol; 2024 Jan; 27(1):. PubMed ID: 38149350
[No Abstract] [Full Text] [Related]
5. Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth.
Jeong MH; Urquhart G; Lewis C; Chi Z; Jewell JL
JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427586
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease.
Armstrong P; Güngör H; Anongjanya P; Tweedy C; Parkin E; Johnston J; Carr IM; Dawson N; Clapcote SJ
Neuropsychopharmacology; 2024 Mar; ():. PubMed ID: 38521860
[TBL] [Abstract][Full Text] [Related]
7. Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and
Jiang M; Tang S; Jenkins MD; Lee AC; Kenou B; Knoer C; Montero Santamaria J; Wu S; Liow JS; Zoghbi SS; Zanotti-Fregonara P; Innis RB; Telu S; Pike VW
J Nucl Med; 2024 May; 65(5):788-793. PubMed ID: 38423785
[TBL] [Abstract][Full Text] [Related]
8. An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands.
Jiang M; Lu S; Telu S; Pike VW
J Med Chem; 2023 Jan; 66(2):1543-1561. PubMed ID: 36608175
[TBL] [Abstract][Full Text] [Related]
9. PET measurements of cAMP-mediated phosphodiesterase-4 with (R)-[11C]rolipram.
Kenk M; Thomas A; Lortie M; Dekemp R; Beanlands RS; Dasilva JN
Curr Radiopharm; 2011 Jan; 4(1):44-58. PubMed ID: 22191614
[TBL] [Abstract][Full Text] [Related]
10. Recent advances of Phosphodiesterase 4B in cancer.
Miao Y; Peng L; Chen Z; Hu Y; Tao L; Yao Y; Wu Y; Yang D; Xu T
Expert Opin Ther Targets; 2023 Feb; 27(2):121-132. PubMed ID: 36803246
[TBL] [Abstract][Full Text] [Related]
11. First-in-Human Evaluation of
Wakabayashi Y; Stenkrona P; Arakawa R; Yan X; Van Buskirk MG; Jenkins MD; Santamaria JAM; Maresca KP; Takano A; Liow JS; Chappie TA; Varrone A; Nag S; Zhang L; Hughes ZA; Schmidt CJ; Doran SD; Mannes A; Zanotti-Fregonara P; Ooms M; Morse CL; Zoghbi SS; Halldin C; Pike VW; Innis RB
J Nucl Med; 2022 Dec; 63(12):1919-1924. PubMed ID: 35772961
[TBL] [Abstract][Full Text] [Related]
12. (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.
Liow JS; Zoghbi SS; Hu S; Hall MD; Hines CS; Shetty HU; Araneta MD; Page EM; Pike VW; Kreisl WC; Herscovitch P; Gottesman MM; Theodore WH; Innis RB
Neuroimage; 2016 Sep; 138():134-140. PubMed ID: 27211474
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.
Schou M; Zoghbi SS; Shetty HU; Shchukin E; Liow JS; Hong J; Andrée BA; Gulyás B; Farde L; Innis RB; Pike VW; Halldin C
Mol Imaging Biol; 2009; 11(1):23-30. PubMed ID: 18800204
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
